Clinical Trial Update: Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating autologous stem cell transplant for neurologic autoimmune diseases is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Vasculitis
• Inflammatory Demyelinating Polyneuropathy
• Lambert-eaton Myasthenic Syndrome
• Multiple Sclerosis
• Myasthenia Gravis
• Neuromyelitis Optica
• Rasmussen Encephalitis
• Stiff-person Syndrome

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Autoimmune Disease, Neurologic Autoimmune Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING